Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.
Spain RI, Paz Soldán MM, Freedman MS, Repovic P, Solomon AJ, Rinker JR, Wallin MT, Haselkorn JK, Stuve O, Gross RH, Waslo CS, Hildebrand A, Morris CD, Mitchell J, Turner AP, Schwartz DL, Metz J, Rooney W. Spain RI, et al. Among authors: repovic p. Neurology. 2026 Jan 13;106(1):e214454. doi: 10.1212/WNL.0000000000214454. Epub 2025 Dec 15. Neurology. 2026. PMID: 41397213 Clinical Trial.
Extended window of relapse recovery in RRMS: an analysis of the DECIDE dataset.
Mostert J, Strijbis EM, D'Haeseleer M, Moral E, Brieva L, Comtois J, Repovic P, Bowen JD, Cutter G, Koch M. Mostert J, et al. Among authors: repovic p. J Neurol Neurosurg Psychiatry. 2025 Oct 9:jnnp-2025-336660. doi: 10.1136/jnnp-2025-336660. Online ahead of print. J Neurol Neurosurg Psychiatry. 2025. PMID: 41072954
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis.
Oh J, Arnold DL, Cree BAC, Ionete C, Kim HJ, Sormani MP, Syed S, Chen Y, Maxwell CR, Benoit P, Turner TJ, Wallstroem E, Wiendl H; Tolebrutinib Phase 3 GEMINI 1 and 2 Trial Group. Oh J, et al. N Engl J Med. 2025 May 15;392(19):1893-1904. doi: 10.1056/NEJMoa2415985. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202623 Clinical Trial.
People with multiple sclerosis help design a tool to measure physical functioning and how it affects their daily lives: a plain language summary.
Kamudoni P, Amtmann D, Johns J, Cook KF, Salem R, Salek S, Raab J, Middleton R, Repovic P, Alschuler KN, Geldern GV, Wundes A, Barrett A, Olayinka-Amao O, Henke C. Kamudoni P, et al. Among authors: repovic p. Neurodegener Dis Manag. 2024;14(5):119-125. doi: 10.1080/17582024.2024.2357002. Epub 2024 Jul 26. Neurodegener Dis Manag. 2024. PMID: 39054910 Free PMC article.
61 results